These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33494881)

  • 61. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn.
    Trevett TN; Dorman K; Lamvu G; Moise KJ
    Am J Obstet Gynecol; 2005 Feb; 192(2):478-82. PubMed ID: 15695990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe perinatal hemolytic disease due to anti-e.
    Soler-Noda G; Romero-Díaz Y; Orbeal-Aldama L; Aquino-Rojas S
    Immunohematology; 2021 Jun; 37(2):72-77. PubMed ID: 34170643
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization.
    Geaghan SM
    Semin Perinatol; 2011 Jun; 35(3):148-54. PubMed ID: 21641488
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss.
    Mohd Nazri H; Noor Haslina MN; Shafini MY; Noor Shaidatul Akmal AR; Rapiaah M; Wan Zaidah A
    Malays J Pathol; 2017 Apr; 39(1):73-76. PubMed ID: 28413208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.
    Rahimi-Levene N; Chezar J; Yahalom V;
    Transfusion; 2020 Nov; 60(11):2684-2690. PubMed ID: 32770778
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies.
    Zonneveld R; van der Meer-Kapelle L; Sylva M; Brand A; Zijlstra M; Schonewille H
    Pediatrics; 2019 Apr; 143(4):. PubMed ID: 30872329
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn.
    Singh B; Chaudhary R; Katharia R
    Transfus Apher Sci; 2021 Feb; 60(1):102958. PubMed ID: 33039278
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn.
    Teng J; Wickman L; Reilly M; Nemeth A; Fischler B; Bohlin K; Tiblad E
    J Perinatol; 2022 Jun; 42(6):702-707. PubMed ID: 35194159
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population.
    Hassan MN; Mohd Noor NH; Johan Noor SR; Sukri SA; Mustafa R; Luc Aster HV
    Asian J Transfus Sci; 2014 Jul; 8(2):113-7. PubMed ID: 25161351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion.
    Seheult JN; Stram MN; Pearce T; Bub CB; Emery SP; Kutner J; Watanabe-Okochi N; Sperry JL; Takanashi M; Triulzi DJ; Yazer MH
    Vox Sang; 2021 Aug; 116(7):831-840. PubMed ID: 33491789
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Red Blood Cell Alloimmunization in the Pregnant Patient.
    Webb J; Delaney M
    Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
    Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
    Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
    Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG.
    Walhof ML; Leon J; Greiner AL; Scott JR; Knudson CM
    J Clin Lab Anal; 2022 Apr; 36(4):e24323. PubMed ID: 35243688
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practices.
    Erhabor O; Azachi WB; Tosan E
    Hum Antibodies; 2020; 28(3):245-252. PubMed ID: 32417769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.